Skip to main content
See every side of every news story
Published loading...Updated

New Inflammatory Pathway Found in RA, Explains Lack of Response to TNF Inhibitors

Researchers at Washington State University have potentially found the reason why tumor necrosis factor inhibitors (TNFis) are an ineffective treatment in as many as 40% of patients with rheumatoid arthritis (RA), by identifying an alternate inflammatory signaling pathway that allows inflammation to persist even when TNF activity is blocked. The study, published in Cellular & Molecular Immunology, found that TNF-α can exploit signaling through th…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Inside Precision Medicine broke the news in on Monday, February 2, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal